Source-grounded facts extracted from EUDA Health Holdings Ltd's SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
EUDA Health Holdings Ltd received a nasdaq compliance regained notice regarding other (rules 5635(c)).
“June 13, 2023, the Company received a letter from Listing Qualifications Staff (the “Staff”) of the Nasdaq Stock Market LLC (“Nasdaq”) citing the Company’s initial non-compliance of Nasdaq Listing Rule 5635(c) but that it has regained compliance with Nasdaq Listing Rule 5635(c) because of the share forfeiture pursuant to the Supplemental Agreement.”
EUDA Health Holdings Ltd terminated Prepaid Forward Agreements with the Sellers valued at Prepaid Forward Transactions accelerated; 1,600,000 ordinary shares due and payable; no further fees (effective 2023-06-08).
“Pursuant to the Amendments, the parties agreed that the Prepaid Forward Transactions shall be accelerated as of the date of the Amendments, and accordingly, the 800,000 ordinary shares (or 1,600,000 ordinary shares in the aggregate), became immediately due and payable to the Sellers upon execution of the Amendments.”
EUDA Health Holdings Ltd amended Amendments to Prepaid Forward Agreements with the Sellers valued at Amended Maturity Consideration to 800,000 ordinary shares per Seller; acceleration of maturity; regi (effective 2023-06-08).
“On June 8, 2023, EUDA and the Sellers entered into amendments to the Prepaid Forward Agreements (together, the “Amendments”), to amend the definition of “Maturity Consideration,” such that, Maturity Consideration shall consist of 800,000 ordinary shares of EUDA to be issued to the each Seller by EUDA.”
EUDA Health Holdings Ltd entered into Supplemental Agreement with Dr. Kelvin Chen valued at 578,439 ordinary shares at $1.47 per share (effective 2023-06-06).
“Pursuant to the Supplemental Agreement, Dr. Chen has agreed to release and discharge KRHSG of all claims in return for 578,439 ordinary shares at $1.47 per share, the closing bid price of EUDA ordinary shares on May 15, 2023.”
Alfred Lim was appointed as Executive Director at EUDA Health Holdings Ltd.
“On June 6, 2023, the Board of Directors of the Company (the “ Board ”) appointed an incumbent director, Alfred Lim, as the Company’s Executive Director, effective immediately.”
Kong-Yew Wong was appointed as Director at EUDA Health Holdings Ltd.
“the Board comprising of Dr. Kelvin Chen, the Company’s Chief Executive Officer, and two independent directors, Mr. Eric Lew and Mr. Alfred Lim voted unanimously to approve the appointment of Mr. Ajay Kumar Rajpal, an existing shareholder of the Company and Dr. Kong-Yew Wong as Class I directors of the Company to fill the vacancies as a result of Mr. Capes’ and Mr. Chia’s removal.”
Ajay Kumar Rajpal was appointed as Director at EUDA Health Holdings Ltd.
“the Board comprising of Dr. Kelvin Chen, the Company’s Chief Executive Officer, and two independent directors, Mr. Eric Lew and Mr. Alfred Lim voted unanimously to approve the appointment of Mr. Ajay Kumar Rajpal, an existing shareholder of the Company and Dr. Kong-Yew Wong as Class I directors of the Company to fill the vacancies as a result of Mr. Capes’ and Mr. Chia’s removal.”
Leonard Chee Hyong Chia was removed as Director at EUDA Health Holdings Ltd.
“Mr. David Capes and Mr. Leonard Chee Hyong Chia were removed from the Company’s Board of Directors effective May 11, 2023 and May 14, 2023, respectively.”
David Capes was removed as Director at EUDA Health Holdings Ltd.
“Mr. David Capes and Mr. Leonard Chee Hyong Chia were removed from the Company’s Board of Directors effective May 11, 2023 and May 14, 2023, respectively.”
EUDA Health Holdings Ltd received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“f this date. However, the Company requires additional time to prepare, review and finalize its financial statements. The Notice has no immediate impact on the listing of the Company’s common stock, which will continue to trade on Nasdaq under the symbol “EUDA”. As required under Nasdaq Listing Rule 5250(b)(2), the Company issued a press release on May 19, 2023, announcing that it had received the Notice. A copy of this press release is attached as Exhibit 99.1 to this Form 8-K. Forward-Looking Statements This Form 8-K contains forward-looking statements, including statements about the financia”
Leonard Chee Hyong Chia was removed as Director at EUDA Health Holdings Ltd.
“the Register Board voted in favor of removing Leonard Chee Hyong Chia as a director of the Company effective immediately.”
Eric Lew was appointed as Chairman of the Board at EUDA Health Holdings Ltd.
“the Board appointed Mr. Lew Chern Yong (Eric) as Chairman of the Board, member and Chairman of the Audit Committee, and Chairman of the Corporate Governance and Nominating Committee, which appointments Mr. Lew accepted effective immediately.”
David Capes was removed as Director and Chairman at EUDA Health Holdings Ltd.
“the Board approved a vote to remove David Capes as a director of the Company effective immediately.”
EUDA Health Holdings Ltd received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).
“April 5, 2023 due to the Company’s non-compliance with Nasdaq Listing Rule 5250(c)(1) (the “Rule” ) as a result of the Company’s failure to timely file its Annual Report on Form 10-K for the fiscal year ended December 31, 2022 (the “ Form 10-K ”). The Rule requires listed companies to timely file all required periodic financial reports with the Securities and Exchange Commission (the “ SEC ”). The Notice states that the Company has 60 calendar days to submit to Nasdaq a plan to regain compliance with the Nasdaq Listing Rules. If Nasdaq accepts the Company’s plan, then Nasdaq may grant the Comp”
Lew Chern Yong (Eric) was appointed as Class I director at EUDA Health Holdings Ltd.
“Effective March 12, 2023, Mr. Lew Chern Yong (Eric) accepted appointment to serve on the Board of Directors (the “Board” ) of EUDA Health Holdings Limited (the “Company” ).”
Gerald Lim resigned as Director at EUDA Health Holdings Ltd.
“the vacancy as a result of Mr. Gerald Lim’s resignation.”
Gerald Lim resigned as Director at EUDA Health Holdings Ltd.
“Effective March 1, 2023, Gerald Lim resigned as a member of the Board of Directors”
Chee Hyong Leonard Chia was appointed as Class II director at EUDA Health Holdings Ltd.
“Mr. Chee Hyong Leonard Chia accepted the appointment to serve as a Class II director of the Company to fill in the vacancy as result of Mr. Chan’s resignation, effective immediately.”
David Francis Capes was appointed as Chairman of the Board at EUDA Health Holdings Ltd.
“Mr. David Francis Capes, a member of the Board, was appointed to serve as Chairman of the Board.”
Thien Su Gerald Lim resigned as Chairman of the Board at EUDA Health Holdings Ltd.
“Mr. Thien Su Gerald Lim, resigned from his position as the Chairman of the Board of Directors (the “Board”) of EUDA Health Holdings Limited (the “Company”), effective immediately.”
Kim Hing Chan resigned as Director at EUDA Health Holdings Ltd.
“Effective January 25, 2023, Kim Hing Chan resigned as a member of the Board of Directors (the “Board” ) of EUDA Health Holdings Limited (the “Registrant” ).”
EUDA Health Holdings Ltd: Company ceased to be a shell company as of the Closing.
“the Company ceased to be a shell company (as defined in Rule 12b-2 of the Exchange Act) as of the Closing.”
EUDA Health Holdings Ltd: Board adopted a new Code of Business Conduct and Ethics (effective 2022-11-17).
“on November 17, 2022, the Board considered and adopted a new Code of Business Conduct and Ethics (the “Code of Ethics”).”
EUDA Health Holdings Ltd: Changed the fiscal year to end on December 31.
“Following the Closing, the Company changed its fiscal year to end on December 31.”
EUDA Health Holdings Ltd: Adopted Amended and Restated Memorandum and Articles of Association, effective as of the Closing Date.
“8i Acquisition 2 Corp. changed its name to EUDA Health Holdings Limited and adopted the Amended and Restated Memorandum and Articles of Association, effective as of the Closing Date.”
EUDA Health Holdings Ltd completed an acquisition involving Watermark Developments Limited (closed 2022-11-17).
“On November 17, 2022 (the "Closing Date" ), EUDA Health Holdings Limited, a British Virgin Islands business company (formerly known as 8i Acquisition 2 Corp.) (the "Company" ), consummated the previously announced business combination contemplated by the Share Purchase Agreement (the "SPA" ) between 8i Acquisition 2 Corp., a BVI business company ( "8i" ), EUDA Health Limited, a British Virgin Islands business company ( "EUDA" ), Watermark Developments Limited, a British Virgin Islands business company ( "Watermark" or the "Seller" ), and Kwong Yeow Liew, dated April 11, 2022 and amended May 30, 2022, June 10, 2022, and September 7, 2022.”
EUDA Health Holdings Ltd entered into Seller Release with Seller.
“ith certain existing stockholders of the Company and with the Seller with respect to their shares of the Company acquired before or pursuant to the Share Purchase, and including the shares issuable on conversion of the warrants issued to the Sponsor in connection with”
EUDA Health Holdings Ltd entered into Lock-up Agreements with the Seller and its designees.
“the Seller and its designees entered into lock-up agreements agreeing, subject to certain exceptions, not to (i) offer, sell contract to sell, pledge or otherwise dispose of, directly or indirectly, any Lockup Shares”
EUDA Health Holdings Ltd amended Amended and Restated Registration Rights Agreement with certain existing stockholders of the Company and with the Seller.
“the Company entered into an amended and restated registration rights agreement (as amended, the “Amended and Restated Registration Rights Agreement”)”
EUDA Health Holdings Ltd entered into Prepaid Forward Agreement with EUDA Health Limited and a certain institutional investor (effective 2022-11-13).
“On November 13, 2022, 8i Acquisition 2 Corp. (the “Company, “8i” or “LAX”), EUDA Health Limited (“EUDA” or “EUDA Health”) and certain institutional investor (the “Seller”) entered into an agreement (the “Prepaid Forward Agreement”) for an equity prepaid forward transaction”
EUDA Health Holdings Ltd shareholders approved To vote to elect five directors effective upon consummation of the Business Combination. at the 2022-11-10 meeting.
“PROPOSAL 4: To vote to elect five directors effective upon consummation of the Business Combination. Each of the director nominees received the following votes: Director Nominee Class For Withhold Wei Wen Kelvin Chen I 8,436,565 932,836 Thien Su Gerald Lim I 8,436,565 932,836 David Francis Capes I 8,436,565 932,836 Alfred Lim II 8,436,565 932,836 Kim Hing Chan II 8,436,565 932,836”
EUDA Health Holdings Ltd shareholders approved To approve, for purposes of complying with applicable listing rules of the Nasdaq Global Market, the issuance of more than 20% of the issued and outstanding Ordinary Shares and the resulting change in control in connection with the Business Combination. at the 2022-11-10 meeting.
“PROPOSAL 3: To approve, for purposes of complying with applicable listing rules of the Nasdaq Global Market (“Nasdaq”), the issuance of more than 20% of the issued and outstanding Ordinary Shares and the resulting change in control in connection with the Business Combination. For Against Abstain Broker Non-Votes 8,335,895 1,030,751 2,755 0”
EUDA Health Holdings Ltd shareholders approved To approve and adopt the following amendments and restatements of 8i amended and restated memorandum and articles of association: a) to amend the name of the combined company from "8i Acquisition 2 Corp." to "EUDA Health Holdings Limited"; and b) to adopt the amended and restated memorandum and arti at the 2022-11-10 meeting.
“PROPOSAL 2: To approve and adopt the following amendments and restatements of 8i amended and restated memorandum and articles of association: a) to amend the name of the combined company from “8i Acquisition 2 Corp.” to “EUDA Health Holdings Limited”; and For Against Abstain Broker Non-Votes 8,335,895 1,030,751 2,755 0 2 b) to adopt the amended and restated memorandum and articles of association of the combined company (the “Amended and Restated Memorandum and Articles of Association”). For Against Abstain Broker Non-Votes 8,335,895 1,030,751 2,755 0”
EUDA Health Holdings Ltd shareholders approved To approve the transactions contemplated under the SPA. at the 2022-11-10 meeting.
“PROPOSAL 1: To approve the transactions contemplated under the SPA. For Against Abstain Broker Non-Votes 8,314,452 1,030,751 24,192 0”
EUDA Health Holdings Ltd terminated Forward Purchase Agreement with Greentree Financial Group, Inc. (effective 2022-11-09).
“On November 9, 2022, 8i and Greentree entered into a Termination Agreement (the “Termination Agreement”) terminating the Forward Purchase Agreement”
EUDA Health Holdings Ltd entered into Prepaid Forward Agreement with certain institutional investor valued at no more than 1,400,000 shares (effective 2022-11-09).
“November 9, 2022, 8i Acquisition 2 Corp. (the “Company, “8i” or “LAX”), EUDA Health Limited (“EUDA” or “EUDA Health”) and certain institutional investor (the “Seller”) entered into an agreement (the “Prepaid Forward Agreement”) for an equity prepaid forward transaction”
EUDA Health Holdings Ltd entered into Forward Purchase Agreement with Greentree Financial Group, Inc. (effective 2022-11-01).
“On November 1, 2022, the Company and Greentree Financial Group, Inc., a Florida corporation (the “ Investor ”) entered into a Forward Share Purchase Agreement (the “ Forward Purchase Agreement ”) pursuant to which, on the sixty (60) day anniversary of the date of the closing of the Share Purchase, the Investor may elect to sell and transfer to the Company, and the Company will purchase, in the aggregate up to 125,000 ordinary shares of the Company, no par value per share (the “ Investor Shares ”) then held by the Investor.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.